SYN002 clinical trials

Renal Ex Vivo SYN002 Perfusion to Eliminate CMV Transmission

This study looks at treating donated kidneys with a special medicine called SYN002 before transplant. The aim is to remove a common virus (CMV) from the kidney, which can cause problems after transplant, making the transplant safer for the patient.